松果体区转移瘤:临床特征、管理策略与生存结局的系统综述
该系统综述纳入31项研究共47例成人松果体区转移瘤患者,肺癌(29.8%)和原发灶不明癌(14.9%)最常见,48.9%患者以症状性松果体转移为首发表现。活检(65.9%)多于切除(34.1%),辅助放化疗后体能状态显著改善,中位总生存3个月。
要点
- 松果体区转移瘤罕见但致残率高,常见头痛(67.4%)和意识模糊(46.5%),脑积水发生率达87.2%。
- 活检(65.9%)较切除(34.1%)更常用,分流方式以内镜下第三脑室造瘘(43.9%)和脑室腹腔分流(26.8%)为主。
- 辅助放化疗后活检(P < 0.001)和切除(P = 0.007)患者体能状态均显著改善,手术方式与生存无关(P = 0.912)。
核心结论
- 松果体区转移瘤致残率显著,活检或手术切除联合辅助放化疗和/或分流可能显著改善体能状态。
- 手术方式(活检 vs 切除)及分流策略对总生存无显著影响(P = 0.912 和 P = 0.822)。
研究设计与样本
- 遵循PRISMA指南检索PubMed、Embase、Scopus和Cochrane数据库的系统综述,纳入报告松果体区转移瘤患者临床结局的研究。
- 共纳入31项研究、47例成人患者。
主要发现
- 最常见原发肿瘤为肺癌(29.8%)和原发灶不明癌(14.9%),48.9%患者症状性松果体转移先于原发肿瘤诊断。
- 最常见症状为头痛(67.4%)和意识模糊(46.5%),Parinaud综合征占46.5%,脑积水占87.2%。
- 活检占65.9%,切除占34.1%;分流方式中内镜下第三脑室造瘘占43.9%,脑室腹腔分流占26.8%。
- 11例(32.3%)接受辅助化疗,32例(68%)接受放疗;治疗后症状改善者占56.6%,脑积水改善者占80.5%。
- 接受辅助放化疗者中,活检(P < 0.001)和切除(P = 0.007)后体能状态均显著改善;手术与活检(P = 0.912)、完全与部分切除(P = 0.220)间无生存差异。
临床怎么用
- 作者认为,活检或手术切除联合辅助放化疗和/或分流可能显著改善体能状态。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pineal region metastases are rare but often cause severe neurologic deficits. Surgical resection and chemoradiotherapy can provide therapeutic benefit. We investigated the literature to analyze clinical characteristics, management strategies, and survival of adult patients with pineal region metastases. METHODS: PubMed, Embase, Scopus, and Cochrane were searched following the PRISMA guidelines, including studies reporting clinical outcomes of patients with pineal region metastases. Clinical presentation, management, and survival were reviewed. RESULTS: We included 31 studies comprising 47 patients. Lung cancer (29.8%) and carcinomas of unknown origin (14.9%) were the most frequent primary tumors. In 48.9% of patients, symptomatic pineal metastases preceded primary tumor diagnosis. Headache (67.4%) and confusion (46.5%) were the most common symptoms. Parinaud syndrome (46.5%) and hydrocephalus (87.2%) were noted. Biopsy (65.9%) was preferred over resection (34.1%), and shunting strategies used were endoscopic third ventriculostomy (43.9%) and ventriculoperitoneal (26.8%). Eleven patients (32.3%) received adjuvant chemotherapy and 32 (68%) received radiotherapy. Posttreatment improvement in symptoms (56.6%) and hydrocephalus (80.5%) were noted. In patients who received adjuvant chemotherapy/radiotherapy, significant improvement in posttreatment performance status occurred with both biopsy (P < 0.001) and resection (P = 0.007). No survival differences were reported between surgery and biopsy (P = 0.912) or between complete and partial resection (P = 0.220). Overall survival was neither influenced by surgical approach (P = 0.157) nor by shunting strategy (P = 0.822). Mean follow-up was 8 months and median overall survival 3 months. Only 2 cases (4.8%) of pineal metastasis showed recurrence. CONCLUSIONS: Pineal region metastases carry significant morbidity. Biopsy or surgical resection, combined with adjuvant chemotherapy/radiotherapy and/or shunting, may significantly improve performance status.
引用
- Palmisciano P, Ogasawara C, Nwagwu CD, et al. Metastases in the Pineal Region: A Systematic Review of Clinical Features, Management Strategies, and Survival Outcomes. World Neurosurg. 2022. PMID: 34999267. doi:10.1016/j.wneu.2022.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。